Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Toluwalase Awoyemi, DPhil student in Nuffield Department of Women's & Reproductive Health, is recognised with an Africa 35.35 Award - a celebration of the top 35 leading young changemakers under 35 in Africa in 2020.

Toluwalase Awoyemi talking to a group of students in Nigeria

35 young changemakers from Africa and the diaspora hailing from 24 countries made it to the list of the Africa 35.35 Awards celebrating African youth and afro-diaspora excellence.

The Africa 35.35 Awards have announced the 35 under 35 most inspiring young personalities in Africa. It is a prestigious list of 35 young personalities aged 18 to 35 who stand out in Africa and around the world.

Selected from more than 500 applicants, these young people living in Africa and in the Diaspora are credited with exceptional achievements in their communities.

We are extremely proud to say that one of the winners is Dr Toluwalase Awoyemi, a Rhodes scholar, DPhil student at the Nuffield Department of Women's Reproductive Health, University of Oxford and co-founder of The Ganglion Initiative. This social enterprise aims to improve college admission services and career counseling really early, engaging students in public high schools across Nigeria. It organizes free webinars for admission to foreign scholarships with a fairly remarkable total audience of 2,221 people in the first two editions.

The full story is available on the Nuffield Department of Women's & Reproductive Health website

Similar stories

Oxford-led team given £6.6m to map uncharted networks in the progression of Parkinson’s

A major new $9 million (£6.6 million) project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.

Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.

Oxford researchers awarded funding to complete community COVID-19 antiviral trial

Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.